Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) ...

British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...

For decades, treatment options for rare diseases have been limited, often focusing on symptom management rather than ...

Medical affairs teams produce evidence-based, non-promotional scientific content for healthcare professionals (HCPs), while ...

The US FDA is coping with a series of Trump-imposed job cuts. These are starting to hamper food safety and pharmaceutical ...